Medical/Pharmaceuticals

FDA Lifts Clinical Hold on NUZ-001

Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...

2025-10-06 14:06 1377

Mediso installs true theranostic TheraMAX SPECT/CT at Heidelberg University Hospital

HEIDELBERG, Germany, Oct. 3, 2025 /PRNewswire/ -- Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital. AnyScan® TRIO-TheraMAX SPEC...

2025-10-03 15:39 1381

MedHub-AI Announces National Reimbursement Approval in Japan for AutocathFFR™

TEL AVIV, Israel, Oct. 3, 2025 /PRNewswire/ -- MedHub-AI today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's AutocathFFR™ System, effectiveOctober 1, 2025. The decision follows regulato...

2025-10-03 07:00 1426

Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States

* The AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation was approved in January 2025 by the FDA to treat the same conditions as the reference product ACTEMRA® (tocilizumab) * AVTOZMA is Celltrion's fifth immunology biologic and seventh biosimilar approved by the FDA * This launch stre...

2025-10-02 20:30 1686

AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

* Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional medicine with state-of-the-art technologies. * Patented Flagship NB-A002 is a First-in-class DNA...

2025-10-02 19:50 4368

Vatech Launches 'Boundless Campaign' to Eliminate Barriers in Dental Care

First milestone: reduced device operation time update eases discomfort for elderly and disabled patients SEOUL, South Korea, Oct. 1, 2025 /PRNewswire/ -- Vatech (KOSDAQ: 043150), a global leader in dental imaging solutions, today announced the launch of its 'Boundless Campaign' a long-term initia...

2025-10-01 21:00 1307

MD Logistics Makes Largest Indiana Business Location Fully cGMP-compliant

- Total Area of 37,000m2, Enhanced Pharmaceutical Logistics Capacity - TOKYO, Oct. 1, 2025 /PRNewswire/ -- MD Logistics LLC (hereinafter "MD Logistics"), a group company of NIPPON EXPRESS HOLDINGS, INC., completed renovation of the South Area of its largest logistics base inPlainfield, in the U....

2025-10-01 15:00 1311

TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational Advancement in Anticoagulant Therapy

TAIPEI, Oct. 1, 2025 /PRNewswire/ -- TAHO Pharmaceuticals Ltd. ("TAHO Pharma") today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world's first Apixaban Oral Dissolving Film (ODF). This submission marks a significant re...

2025-10-01 14:16 1391

Full-Life Technologies Announces US$77 Million Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Manufacturing Capabilities

* Series C led by Junson Capital along with new investor syndicate and existing shareholders * Funding will further advance Full-Life's global radiopharmaceutical pipeline and manufacturing capabilities inBelgium * Additional debt financing provides an alternative financing solution for Ful...

2025-09-30 08:00 1459

United Imaging Announces the uDR® Aurora CX

"Designed for Freedom," the newly FDA-cleared system will be showcased at RSNA.  HOUSTON, Sept. 29, 2025 /PRNewswire/ -- United Imaging has announced its new digital radiography system,uDR Aurora CX, which is intended to introduce computer vision, automation, and AI diagnostics into one of the mo...

2025-09-30 00:00 1144

Lumonus Announces Transformative Multi-Year Licensing Agreement with Smarter Radiation Oncology® to bring evidenced-based directives to U.S. cancer centers

NEW YORK and SYDNEY, Sept. 29, 2025 /PRNewswire/ -- Lumonus , a healthcare technology company transforming cancer care with its AI-powered platform, today announced a multi-year agreement with Smarter Radiation Oncology® (SRO), a company incubated by Northwell Health. T...

2025-09-30 00:00 1244

Smartee Chief Scientist Prof. Gang Shen Recognized Among World's Top 2% Scientists for Orthodontic Contributions

SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ByBo Dental, has once again been named to theWorld's Top 2% Scientistslist, compiled by Stanford University in partnership with Elsevi...

2025-09-29 17:56 1083

Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ -- Hanmi Pharm announced on September 29 that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gile...

2025-09-29 17:45 990

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem. SHANGHAI, Sept. 29, 2025 /PRNewswire/ -- Viva Biotech announced today that it has been honored...

2025-09-29 17:00 872

International Health Experts: China's Experience Benefits Global Health Governance

BEIJING, Sept. 28, 2025 /PRNewswire/ -- A news report from Xinhua Finance, "Over the past few years, we have seenChina gradually increase its universal health coverage, boost investment, and place great emphasis on preventive medicine. While advancing its 'Healthy China 2030' initiative,China has...

2025-09-28 20:50 1366

The 2025 BPD Singapore Conference Has Concluded Successfully! Jointly Embarking on a New Journey for Global Development

SINGAPORE, Sept. 26, 2025 /PRNewswire/ -- The 2025 BPD (Biopharmaceutical Bioprocess Development) Singapore Summit, which co-hosted by WuXi XDC (Stock Code: 2268.HK), was successfully concluded fromSeptember 24-26, 2025. The conference brought together leading biopharmaceutical companies and rese...

2025-09-27 10:45 3596

Datasea Reports Record Fiscal Year 2025 Revenue of $71.62 Million, Up 199% Year-over-Year

DTSS Achieves Fourth Quarter Net Income Breakeven Driven by Cutting-Edge Acoustics and AI Multimodal Digitalization;  Ongoing Commercialization Updates in the Coming Weeks BEIJING, Sept. 26, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech ente...

2025-09-26 21:30 4627

Concord Medical Reports Financial Results for the First Half of 2025

BEIJING, Sept. 26, 2025 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention inChina, today announced its unaudited consolidated financial results for t...

2025-09-26 19:30 3209

Jacobio Chairman and Concerted Parties Increase Shareholding by Nearly HK$100 Million, Demonstrating Confidence in Long-term Growth

BEIJING, SHANGHAI and BOSTON, Sept. 25, 2025 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK)today announced that its Chairman and Chief Executive Officer, Dr. Yinxiang Wang, together with concerted parties, have recently increased their shareholding in the Company by 11.06 million shares, repr...

2025-09-26 08:47 1579

Bambusa Therapeutics Announces Highly Positive Healthy Volunteer Results and First Atopic Dermatitis Patient Dosed in Phase I Trial of BBT001

BOSTON, Sept. 25, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation, today announced two landmark achievements for its lead program, BBT001. Last week, Ba...

2025-09-25 22:04 1723
1 ... 10111213141516 ... 247